Literature DB >> 3110389

Fulminant hepatitis in children in Taiwan: the important role of hepatitis B virus.

M H Chang, C Y Lee, D S Chen, H C Hsu, M Y Lai.   

Abstract

In a recent period of 64 months, fulminant hepatitis was diagnosed in 17 children at National Taiwan University Hospital. Eleven patients were younger than 12 months of age. Hepatitis A IgM antibody and delta-antibody were negative in all 17. Eleven (65%) patients had hepatitis B core IgM antibody, fulminant hepatitis B. Two to 5 months before onset of hepatitis. Five of the 11 children had received blood transfusions. Three of the five donors had hepatitis B e antibody (anti-HBe) and were hepatitis B virus DNA-negative hepatitis B surface antigen (HBsAg) carriers; another two were HBsAg negative, screened by a less sensitive reverse passive hemagglutination method. The mothers of all six infants younger than 6 months of age had HBsAg. HBe antigen and antibody were studied in five of these six mothers; all five had anti-HBe. We conclude that hepatitis B virus is the most important cause of fulminant hepatitis in children in Taiwan.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3110389     DOI: 10.1016/s0022-3476(87)80338-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  10 in total

1.  Fulminant hepatitis B in infants.

Authors:  S Hatun; T Tezic
Journal:  BMJ       Date:  1992-07-04

Review 2.  Natural history of hepatitis B virus infection: pediatric perspective.

Authors:  Yen-Hsuan Ni
Journal:  J Gastroenterol       Date:  2010-09-02       Impact factor: 7.527

Review 3.  Prevention of hepatitis B.

Authors:  Mei-Hwei Chang; Ding-Shinn Chen
Journal:  Cold Spring Harb Perspect Med       Date:  2015-03-02       Impact factor: 6.915

Review 4.  Hepatitis B virus mutation in children.

Authors:  Mei-Hwei Chang
Journal:  Indian J Pediatr       Date:  2006-09       Impact factor: 1.967

Review 5.  Current hepatitis B virus infection situation in Indonesia and its genetic diversity.

Authors:  Maria Inge Lusida; Yoshihiko Yano
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

6.  Low level virus replication in infants with vertically transmitted fulminant hepatitis and their anti-HBe positive mothers.

Authors:  E Schaefer; H Koeppen; S Wirth
Journal:  Eur J Pediatr       Date:  1993-07       Impact factor: 3.183

7.  Fulminant hepatitis B in an infant born to a hepatitis Be antibody positive, DNA negative carrier.

Authors:  J Vanclaire; C Cornu; E M Sokal
Journal:  Arch Dis Child       Date:  1991-08       Impact factor: 3.791

8.  Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial.

Authors:  Chunfeng Qu; Taoyang Chen; Chunsun Fan; Qimin Zhan; Yuting Wang; Jianhua Lu; Ling-ling Lu; Zhengping Ni; Fei Huang; Hongyu Yao; Jian Zhu; Jian Fan; Yuanrong Zhu; Zhiyuan Wu; Guoting Liu; Wenhong Gao; Mengya Zang; Dongmei Wang; Min Dai; Chu Chieh Hsia; Yawei Zhang; Zongtang Sun
Journal:  PLoS Med       Date:  2014-12-30       Impact factor: 11.069

9.  Infantile hepatitis B in immunized children: risk for fulminant hepatitis and long-term outcomes.

Authors:  Yu-Ru Tseng; Jia-Feng Wu; Man-Shan Kong; Fu-Chang Hu; Yao-Jong Yang; Chun-Yan Yeung; Fu-Chen Huang; I-Fei Huang; Yen-Hsuan Ni; Hong-Yuan Hsu; Mei-Hwei Chang; Huey-Ling Chen
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

Review 10.  The clinical implications of hepatitis B virus genotypes and HBeAg in pediatrics.

Authors:  Anna Kramvis
Journal:  Rev Med Virol       Date:  2016-05-03       Impact factor: 6.989

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.